C
CRINETICS PHARMACEUTICALS INC
NASDAQ: CRNX (Crinetics Pharmaceuticals, Inc.)
Kemas kini terakhir: semalam, 12:52AM39.02
0.24 (0.62%)
| Penutupan Terdahulu | 38.78 |
| Buka | 38.84 |
| Jumlah Dagangan | 1,060,568 |
| Purata Dagangan (3B) | 1,114,941 |
| Modal Pasaran | 4,114,250,752 |
| Harga / Jualan (P/S) | 477.62 |
| Harga / Buku (P/B) | 4.12 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2026 |
| Margin Operasi (TTM) | -30,860.11% |
| EPS Cair (TTM) | -3.80 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -43.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 4.05% |
| Nisbah Semasa (MRQ) | 22.53 |
| Aliran Tunai Operasi (OCF TTM) | -261.57 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -155.77 M |
| Pulangan Atas Aset (ROA TTM) | -20.13% |
| Pulangan Atas Ekuiti (ROE TTM) | -30.84% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Crinetics Pharmaceuticals, Inc. | Menurun | Menaik |
AISkor Stockmoo
1.0
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.5 |
| Purata | 1.00 |
|
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 2.03% |
| % Dimiliki oleh Institusi | 112.39% |
| Julat 52 Minggu | ||
| Median | 96.00 (146.03%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citizens | 02 Mar 2026 | 96.00 (146.03%) | Beli | 40.68 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |